Literature DB >> 26600310

Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice.

Alton G Sutter1, Arun P Palanisamy1, Julie H Lench1, Scott Esckilsen1, Tuoyu Geng2, David N B Lewin3, Lauren A Cowart2, Kenneth D Chavin1.   

Abstract

Nonalcoholic steatohepatitis (NASH) is currently the third most common cause of end stage liver disease necessitating transplantation. The question remains how inflammation and NASH develop in the setting of nonalcoholic fatty liver disease (NAFLD) and steatosis. Understand the roles of toll-like receptor 4 (TLR4) and dietary fats in the development of hepatic inflammation. Wild-type and TLR4 KO mice were fed a standard high fat diet (LD), a high saturated fat diet (MD), or an isocaloric control diet (CD). Sera and tissue were analyzed for development of hepatic steatosis, inflammation, and injury. MD induced features of hepatic steatosis and inflammation in wild-type, but not in TLR4 KO, mice. TLR4 KO prevented MD induced increases in NAFLD activity scores, serum alanine aminotransferase levels, and inflammatory cytokine expression. Inflammatory cell infiltration and cytokine expression were also lower in the TLR4 KO mice livers than wild-type mice fed MD. Hepatic expression of Collagen I transcripts and collagen deposition were also decreased in the TLR4 KO MD animals. Results show that TLR4 plays a critical role in the effects of dietary fat composition on the development of hepatic steatosis, inflammation, and injury consistent with nonalcoholic steatohepatitis. J. Cell. Biochem. 117: 1613-1621, 2016.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  DIET; LIVER; NASH; STEATOSIS; TLR4

Mesh:

Substances:

Year:  2015        PMID: 26600310      PMCID: PMC6032519          DOI: 10.1002/jcb.25453

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  35 in total

1.  Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice.

Authors:  William L Holland; Benjamin T Bikman; Li-Ping Wang; Guan Yuguang; Katherine M Sargent; Sarada Bulchand; Trina A Knotts; Guanghou Shui; Deborah J Clegg; Markus R Wenk; Michael J Pagliassotti; Philipp E Scherer; Scott A Summers
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

2.  Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.

Authors:  K Tomita; G Tamiya; S Ando; K Ohsumi; T Chiyo; A Mizutani; N Kitamura; K Toda; T Kaneko; Y Horie; J-Y Han; S Kato; M Shimoda; Y Oike; M Tomizawa; S Makino; T Ohkura; H Saito; N Kumagai; H Nagata; H Ishii; T Hibi
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

Review 3.  Sphingolipid metabolism and analysis in metabolic disease.

Authors:  Sarah E Brice; L Ashley Cowart
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

4.  Dietary fat content modifies liver fat in overweight nondiabetic subjects.

Authors:  Jukka Westerbacka; Katriina Lammi; Anna-Maija Häkkinen; Aila Rissanen; Irma Salminen; Antti Aro; Hannele Yki-Järvinen
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

5.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

Authors:  Kanji Yamaguchi; Liu Yang; Shannon McCall; Jiawen Huang; Xing Xian Yu; Sanjay K Pandey; Sanjay Bhanot; Brett P Monia; Yin-Xiong Li; Anna Mae Diehl
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

6.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

Review 7.  New cellular and molecular immune pathways in ischemia/reperfusion injury.

Authors:  P Boros; J S Bromberg
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

8.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

Review 9.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

10.  C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.

Authors:  Amrom E Obstfeld; Eiji Sugaru; Marie Thearle; Anne-Marie Francisco; Constance Gayet; Henry N Ginsberg; Eleanore V Ables; Anthony W Ferrante
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more
  9 in total

1.  Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy.

Authors:  Maria Nicoline Baandrup Kristiansen; Sanne Skovgård Veidal; Kristoffer Tobias Gustav Rigbolt; Kirstine Sloth Tølbøl; Jonathan David Roth; Jacob Jelsing; Niels Vrang; Michael Feigh
Journal:  World J Hepatol       Date:  2016-06-08

2.  Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis.

Authors:  Lauren K Barron; James W Bao; Bola G Aladegbami; Jason J Colasanti; Jun Guo; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2017-03-16       Impact factor: 2.545

Review 3.  Prominent Receptors of Liver Sinusoidal Endothelial Cells in Liver Homeostasis and Disease.

Authors:  Ekta Pandey; Aiah S Nour; Edward N Harris
Journal:  Front Physiol       Date:  2020-07-21       Impact factor: 4.566

4.  Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH.

Authors:  David Montefusco; Maryam Jamil; Melissa A Maczis; William Schroeder; Moshe Levi; Suman Ranjit; Jeremy Allegood; Dipankar Bandyopadhyay; Reuben Retnam; Sarah Spiegel; L Ashley Cowart
Journal:  Mol Metab       Date:  2022-06-06       Impact factor: 8.568

5.  Cimifugin Ameliorates Lipotoxicity-Induced Hepatocyte Damage and Steatosis through TLR4/p38 MAPK- and SIRT1-Involved Pathways.

Authors:  Wenwen Yang; Linwensi Zhu; Shanglei Lai; Qinchao Ding; Tiantian Xu; Rui Guo; Xiaobing Dou; Hui Chai; Zhiling Yu; Songtao Li
Journal:  Oxid Med Cell Longev       Date:  2022-03-20       Impact factor: 6.543

Review 6.  Targeting fibrosis, mechanisms and cilinical trials.

Authors:  Manyu Zhao; Liqun Wang; Mengzhu Wang; Shijie Zhou; Ying Lu; Huijie Cui; Alexandra C Racanelli; Ling Zhang; Tinghong Ye; Bisen Ding; Ben Zhang; Jinliang Yang; Yuqin Yao
Journal:  Signal Transduct Target Ther       Date:  2022-06-30

Review 7.  Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review.

Authors:  Narjes Nasiri-Ansari; Theodoros Androutsakos; Christina-Maria Flessa; Ioannis Kyrou; Gerasimos Siasos; Harpal S Randeva; Eva Kassi; Athanasios G Papavassiliou
Journal:  Cells       Date:  2022-08-12       Impact factor: 7.666

8.  Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae.

Authors:  Muhammad Imran; Odile Sergent; Arnaud Tête; Isabelle Gallais; Martine Chevanne; Dominique Lagadic-Gossmann; Normand Podechard
Journal:  Biomolecules       Date:  2018-05-14

Review 9.  Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis.

Authors:  Kia M Peters; Rachel B Wilson; Nica M Borradaile
Journal:  Curr Opin Lipidol       Date:  2018-10       Impact factor: 4.776

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.